Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

rs10010131A in WFS1 is Associated with Elevated Serum Urea in Type 2 Diabetes Patients Treated with SGLT2 Inhibitors

Saved in:
Bibliographic Details
Published in:Therapeutics and Clinical Risk Management
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867301676491210754
collection WordPress RSS
FRELIP Feed Integration
container_title Therapeutics and Clinical Risk Management
description
discipline_display Emergency and Intensive Critical Care
discipline_facet Emergency and Intensive Critical Care
format Online Article
RSS Article
genre Journal Article
id rss_article:74008
institution FRELIP
journal_source_facet Therapeutics and Clinical Risk Management
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle rs10010131A in WFS1 is Associated with Elevated Serum Urea in Type 2 Diabetes Patients Treated with SGLT2 Inhibitors
Emergency and Intensive Critical Care
General
Emergency and Intensive Critical Care
sub_discipline_display General
sub_discipline_facet General
subject_display Emergency and Intensive Critical Care
General
Emergency and Intensive Critical Care
Emergency and Intensive Critical Care
General
Emergency and Intensive Critical Care
subject_facet Emergency and Intensive Critical Care
General
Emergency and Intensive Critical Care
title rs10010131A in WFS1 is Associated with Elevated Serum Urea in Type 2 Diabetes Patients Treated with SGLT2 Inhibitors
title_auth rs10010131A in WFS1 is Associated with Elevated Serum Urea in Type 2 Diabetes Patients Treated with SGLT2 Inhibitors
title_full rs10010131A in WFS1 is Associated with Elevated Serum Urea in Type 2 Diabetes Patients Treated with SGLT2 Inhibitors
title_fullStr rs10010131A in WFS1 is Associated with Elevated Serum Urea in Type 2 Diabetes Patients Treated with SGLT2 Inhibitors
title_full_unstemmed rs10010131A in WFS1 is Associated with Elevated Serum Urea in Type 2 Diabetes Patients Treated with SGLT2 Inhibitors
title_short rs10010131A in WFS1 is Associated with Elevated Serum Urea in Type 2 Diabetes Patients Treated with SGLT2 Inhibitors
title_sort rs10010131a in wfs1 is associated with elevated serum urea in type 2 diabetes patients treated with sglt2 inhibitors
topic Emergency and Intensive Critical Care
General
Emergency and Intensive Critical Care
url https://www.dovepress.com/rs10010131a-in-wfs1-is-associated-with-elevated-serum-urea-in-type-2-d-peer-reviewed-fulltext-article-TCRM